Systematic Financial Management LP lowered its holdings in Aetna Inc. (NYSE:AET) by 5.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,014 shares of the company’s stock after selling 1,155 shares during the period. Systematic Financial Management LP’s holdings in Aetna were worth $3,182,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in AET. FMR LLC increased its position in shares of Aetna by 73.8% in the second quarter. FMR LLC now owns 13,736,800 shares of the company’s stock worth $2,085,659,000 after acquiring an additional 5,833,567 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in shares of Aetna by 9,446.2% during the second quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after purchasing an additional 4,283,553 shares during the period. Capital World Investors boosted its holdings in shares of Aetna by 8.9% during the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after purchasing an additional 1,688,767 shares during the period. Samlyn Capital LLC acquired a new stake in shares of Aetna during the second quarter worth approximately $77,170,000. Finally, Harbour Capital Advisors LLC boosted its holdings in shares of Aetna by 15,083.0% during the second quarter. Harbour Capital Advisors LLC now owns 504,076 shares of the company’s stock worth $3,320,000 after purchasing an additional 500,756 shares during the period. 88.41% of the stock is currently owned by institutional investors and hedge funds.

Shares of Aetna Inc. (NYSE:AET) opened at $176.46 on Friday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. The stock has a market cap of $57,471.87, a P/E ratio of 17.26, a price-to-earnings-growth ratio of 1.61 and a beta of 0.61. Aetna Inc. has a one year low of $116.04 and a one year high of $184.98.

Aetna (NYSE:AET) last posted its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.06 by $0.39. The firm had revenue of $14.99 billion during the quarter, compared to analysts’ expectations of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The company’s revenue was down 5.0% compared to the same quarter last year. During the same period in the previous year, the company earned $2.07 earnings per share. equities research analysts predict that Aetna Inc. will post 9.78 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date was Wednesday, October 11th. Aetna’s dividend payout ratio (DPR) is presently 37.04%.

In other news, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the sale, the executive vice president now directly owns 33,563 shares in the company, valued at $5,465,734.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the sale, the president now owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is owned by insiders.

Several research firms recently commented on AET. Piper Jaffray Companies restated a “hold” rating and set a $187.00 price target on shares of Aetna in a report on Friday, November 3rd. Raymond James Financial, Inc. upgraded shares of Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 price target for the company in a report on Friday, November 3rd. Credit Suisse Group began coverage on shares of Aetna in a report on Thursday, November 2nd. They set a “neutral” rating and a $174.00 price target for the company. Zacks Investment Research cut shares of Aetna from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Finally, Citigroup Inc. raised their price target on shares of Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a report on Thursday, November 2nd. Eleven investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Aetna currently has an average rating of “Buy” and an average price target of $172.36.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://www.watchlistnews.com/systematic-financial-management-lp-sells-1155-shares-of-aetna-inc-aet/1725512.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.